The South East Asia spinal implants market size is expected to reach USD 3.33 billion by 2030, registering a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of spinal disorders, such as trauma, fractures, deformities, lumbar stenosis, and degenerative disc diseases, is driving the market growth. The growing demand for minimally invasive surgical procedures is also bolstering the market growth. Technological advancements and innovations in spinal implants are driving the adoption of these devices.
The growing number of healthcare facilities, such as Ambulatory Surgery Centers (ASCs), hospitals, and specialty clinics, is expected to boost the demand. These surgical procedures are minimally invasive with minimal collateral tissue damage, reduced hospitalization stays, and quicker recovery. The COVID-19 pandemic had a negative impact on the market and overburdened the healthcare systems. The pandemic forced government authorities to impose travel restrictions and lockdowns to curb the transmission rate. These measures led to structural changes in operating rooms, workforce, and pre-op setups, which further resulted in postponing elective or non-emergent spinal surgeries.
The significant decline in the number of surgical procedures was due to the shortage of testing facilities, lack of Personal Protective Equipment (PPE), and increased number of COVID-19 patients, which forced healthcare facilities to postpone and prioritize surgeries. The spinal infusion implants segment dominated the market in 2020 due to the varied availability of fusion implants, such as pedicle screw systems, rods, plates, and interbody fusion devices used in strengthening and stabilizing the spine. The growing prevalence of spinal disorders coupled with the growing geriatric population prone to spine injuries and trauma is expected to drive the segment growth.
Request a free sample copy or view report summary: South East Asia Spinal Implants Market Report
The titanium-based implants segment dominated the market owing to the high strength, flexibility, biocompatibility, and tendency of titanium to get alloyed easily to form stronger material, and corrosion-resistant
The degenerative disc disease segment dominated the market in 2024 owing to the increased prevalence of lower back pain and neck pain among adults aged 40 years and above
The hospitals segment dominated the market owing to the growing influx of patients suffering from spinal disorders, such as fractures, trauma, deformities, degenerative disc diseases, and lumbar stenosis
The growing trend of minimally invasive surgeries is driving the volume of surgeries being performed in hospitals and contributing to the segment growth
China was the dominant country owing to the availability of developed healthcare infrastructure and readiness to adopt advanced technologies
Improvements in healthcare infrastructure and rising healthcare expenditure are expected to drive the market growth in the country over the coming years
Grand View Research has segmented the South East Asia spinal implants market based on product, raw material, application, end use, and countries:
South East Asia Spinal Implants Product Outlook (Revenue, USD Billion, 2018 - 2030)
Spinal Fusion Implants
Plates
Rods
Pedicle Screw Systems
Interbody Fusion Devices (Spinal Cages)
Non-Fusion Implants
Expandable Cages
Others
South East Asia Spinal Implants Raw Material Outlook (Revenue, USD Billion, 2018 - 2030)
Titanium
Titanium Alloy
Stainless Steel
Polyetheretherketone (PEEK)
South East Asia Spinal Implants Application Outlook (Revenue, USD Billion, 2018 - 2030)
Spine Fractures
Spinal Stenosis
Degenerative Disc Disease
Complex Deformity
Others
South East Asia Spinal Implants End Use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Clinics
List Of Key Players South East Asia Spinal Implants Market
Medtronic
Medical Device Business Services, Inc.
NuVasive, Inc.
Stryker
Globus Medical
Zimmer Biomet
RTI Surgical
Orthofix Medical Inc.
SeaSpine.
B. Braun SE
"The quality of research they have done for us has been excellent..."